Iovance Biotherapeutics (NASDAQ: IOVA) aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune cells to attack cancer.
23 people · 0 jobs
11 people · 0 jobs
13 people · 0 jobs
11 people · 0 jobs
8 people · 0 jobs
6 people · 0 jobs
Editas Medicine
5 followers
Arcus Biosciences
3 followers
Gilead Sciences
159 followers
Regeneron
130 followers
Illumina
79 followers
Agilent Technologies
81 followers
Verily Life Sciences
45 followers
Alexion Pharmaceuticals
44 followers
GRAIL
28 followers
Cytiva
16 followers
CRISPR Therapeutics
11 followers
Explore companies